Clinical Affiliate Lupus Therapeutics Expands Peer-to-Peer Program
New Centralized Model to Include Hundreds of Research Sites Across North America The clinical affiliate of the Lupus Research Alliance,...
Search Results
You searched for: Research Portfolio
Results found: 856
VALUE Study Results Reported at EULAR
MADRID, Spain. June 13, 2019 – Results of the first clinical trial conducted through the Lupus Research Alliance Lupus...
New Biomarker Research Fast-Tracked
July 30, 2019
Progentec Diagnostics announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant from the National...
Condolences to Family of Long-Time Donors
Posted July 23, 2018 in New York Times
We at the Lupus Research Alliance extend our deepest condolences to the...
Family Planning and Lupus
The LRA is committed to supporting research and resources to better address the complexities of pregnancy in lupus. This...
LRA-Funded Researcher Finds New Biomarkers for Lupus Nephritis
August 7, 2019
Dr. Chandra Mohan discovered that blood clotting proteins are higher in the urine of people with lupus...
3 Questions with Dr. Erika Moore
Feb. 22, 2023
The Lupus Research Alliance has funded some of the biggest breakthroughs in lupus research, and we’re pleased...
Lupus ABC Spearheading a New Era of Collaboration to Advance Lupus Drug Development | Nature Reviews Rheumatology
We are pleased to share an article published in @Nature Reviews Rheumatology highlighting the notable progress and accomplishments of the...
LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment
March 30, 2021
Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...
Congress Passes Budget With $10M for Lupus Research Program
Congress and passed and President Biden signed the 2024 spending bills, which include priorities that you, our advocates requested...
Lupus Multi-Cultural Engagement Partnership
The Lupus Research Alliance and the National Minority Quality Forum Announce Lupus Multi-Cultural Engagement Partnership
NEW YORK, December 19, 2017 --...
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...